The European poultry division 2 Sisters Storteboom, part of 2 Sisters Food Group, has signed a contract with Evonik for using its intelligent poultry management software Porphyrio® to optimize their poultry value chain as consumer demands for food quality, health, and animal welfare are on the rise.
“In order to keep and improve our competitive position in the European market, we see the need for more organisation and communication in the supply chain. We strongly believe in the holistic approach of big data and biostatistics backed up with the nutritional and health expertise from Evonik. The Porphyrio® solution allows us to optimize our production to ensure the right products at the right time as well as to strengthen the relation with our broiler suppliers and agri-business partners and position ourselves as innovation leaders in the sector towards our customers”, says Harm Laros, Managing Director at 2 Sisters Storteboom and head of European Poultry.
The company is a chicken specialist and caters for chains such as KFC and McDonald’s as well as major retailers such as Aldi and Jumbo. 2 Sisters Storteboom is part of the Birmingham-based 2 Sisters Food Group with more than 40 manufacturing sites across the UK, Netherlands, and Poland.
Porphyrio® is a cloud-based software for collecting, processing, and analyzing livestock data in poultry meat and egg production. The Porphyrio® software enables livestock producers to better manage, predict, and optimize operations with the help of big data, biostatistics, and smart algorithms. Porphyrio is the digital pillar of Evonik’s precision livestock farming business to support the performance of the company’s animal nutrition growth engine.
“We are delighted about the collaboration and we believe that our software is a quantum leap for 2 Sisters Storteboom to deliver exactly the product that their customers and hence consumers want. Our software helps poultry producers gain a much better and precise understanding of their own production process – that’s the foundation for optimization. This way, we strive to become a preferred partner for supporting poultry businesses on the digital transformation”, says Kristof Mertens, Managing Director at Evonik Porphyrio (Belgium).
Evonik’s Nutrition & Care segment has long-standing experience in modern livestock nutrition. Connecting nutritional products with data- and knowledge-based services and digital technologies, Evonik assumes a leading role in precision livestock farming.
Alongside Porphyrio®, the recently launched pathogen screening system ScreenFloX® are essential pillars of Evonik’s precision livestock farming business, reflecting the company’s ambition to turn into a holistic system provider for healthy and sustainable food solutions.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales from continuing operations in Asia Pacific North reached €1.97 billion in 2018. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around
€4.6 billion in 2018.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.